Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dr Alexander (Sandy) Douglas, an investigator at the Jenner Institute, Nuffield Department of Medicine, has recently received two prestigious Wellcome accolades.

Dr Alexander (Sandy) Douglas in a medical research laboratory

Dr Sandy Douglas was awarded a 5 year Wellcome Stage 2 Clinical Research Career Development Fellowship, receiving £1.3m of funding to investigate development of new vaccines against rabies and Epstein Barr virus. On the back of his strong fellowship application, he also was one of four recipients of a Wellcome-Beit prize, worth another £25k of funding. This prize is awarded annually to Wellcome’s strongest applicants across their range of intermediate-level clinical & non-clinical fellowship schemes.

Dr Sandy Douglas commented upon receiving the news: “I’m really grateful to Wellcome for the opportunity to start work on vaccines against Epstein Barr virus. As well as glandular fever the virus causes many cancers and seems to be a prerequisite for development of multiple sclerosis, but it’s a tricky target and has been quite neglected by vaccine developers. The Jenner & the wider NDM are the perfect setting to enable progress in this important area.”